ITI Pharma and Healthcare Fund Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

ITI Pharma and Healthcare Fund Growth Fund Overview

Min. investment

SIP ₹500 & Lump. ₹5000

AUM (Fund size)

₹276 Cr

Lock In Period

N/A

Expense Ratio

2.63

Exit Load

If redeemed/Switched out on or before 3 Months from the date of allotment; Exit Load is 0.50%.Exit Load after completion of 3 months - Nil.

Benchmark

NIFTY Healthcare Total Return Index

ITI Pharma and Healthcare Fund Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M0.42-0.822.53
6M20.023.6029.45
1Y9.844.1826.84
3Y17.3013.9590.66

Portfolio Analysis

  • Equity: 99.27%
  • Debt: 0.73%
  • Others
As on: 2026-08-31
View allocation % by

1. Sun Pharmaceutical Industries Limited12.58%
2. Divi's Laboratories Limited9.23%
3. Torrent Pharmaceuticals Limited4.75%
4. Dr. Reddy's Laboratories Limited4.31%
5. Cipla Limited4.22%
6. Laurus Labs Limited4.02%
7. Aurobindo Pharma Limited3.97%
8. Mankind Pharma Limited3.31%
9. Neuland Laboratories Limited3.18%
10. Cohance Lifesciences Limited3.10%
11. Alkem Laboratories Limited2.92%
12. Lupin Limited2.43%
13. Abbott India Limited1.97%
14. IPCA Laboratories Limited1.92%
15. Shilpa Medicare Limited1.59%
16. Sai Life Sciences Limited1.59%
17. Piramal Pharma Limited1.32%
18. Anthem Biosciences Limited1.25%
19. Glenmark Pharmaceuticals Limited1.15%
20. GlaxoSmithKline Pharmaceuticals Limited1.02%
21. Biocon Limited0.87%
22. Supriya Lifescience Limited0.81%
23. Zydus Lifesciences Limited0.71%
24. Caplin Point Laboratories Limited0.61%
25. Syngene International Limited0.60%

1. Apollo Hospitals Enterprise Limited5.72%
2. Max Healthcare Institute Limited4.84%
3. Global Health Limited2.98%
4. Fortis Healthcare Limited2.82%
5. Healthcare Global Enterprises Limited1.55%
6. Aster DM Quality Care Limited1.47%
7. Thyrocare Technologies Limited1.05%
8. Rainbow Childrens Medicare Limited0.93%
9. Metropolis Healthcare Limited0.74%

1. Poly Medicure Limited1.50%

1. Shaily Engineering Plastics Limited1.25%
No Data Found
No Data Found

About Fund ITI Pharma and Healthcare Fund Growth

ITI Pharma and Healthcare Fund Growth managed by ITI Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹276 Crore. The fund benchmarks its performance against the NIFTY Healthcare Total Return Index while maintaining an expense ratio of 2.63. Under the expert guidance of Animesh Singh ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Animesh Singh

Mr. Animesh Singh holds Post Graduate Diploma in Management, Bachelor of Honours -(Economics) CFA - USA Certification. Prior to joining the ITI AMC, he was associated with Julius Baer wealth Advisor, Centrum Wealth, Nippon Life India Asset Management Ltd, Reliance Portfolio Management Services, KSBL and SSKI Securities.

Peer Comparison

Fund NameRatingsAUMExpense Ratio
PGIM India Healthcare Fund Growth0125 CR2.58
Nippon India Pharma Fund Growth49,479 CR1.84
ITI Pharma and Healthcare Fund Growth0276 CR2.63
UTI Healthcare Fund Growth31,443 CR2.2
SBI Healthcare Opportunities Fund Growth35,796 CR2
Fund Name1Y3Y
This FundPGIM India Healthcare Fund Growth22.04250
This FundNippon India Pharma Fund Growth9.38359.9827
This FundITI Pharma and Healthcare Fund Growth9.840161.4053
This FundUTI Healthcare Fund Growth14.855183.167
This FundSBI Healthcare Opportunities Fund Growth19.637984.8312

ITI Pharma and Healthcare Fund Growth FAQs

ITI Pharma and Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of ITI Pharma and Healthcare Fund Growth is 2.63. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

ITI Pharma and Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : 0.42%
  • 6 Months : 20.02%
  • 1 Year : 9.84%
  • 3 Years : 17.30%
Returns of ITI Pharma and Healthcare Fund Growth are updated daily based on NAV of ₹ 18.0364 as on Sep 17,2026. Since inception, the return has been 61.41%.

You can invest in ITI Pharma and Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of ITI Pharma and Healthcare Fund Growth is ₹276 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in ITI Pharma and Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.